S 1082

Title

A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize and amend the prescription drug user fee provisions, and for other purposes.

Read more information on this bill at the Library of Congress.

Date	Chamber	Result	Vote
5/9/07	Senate	Passed	Session 1, roll call 157: On Passage of the Bill S.1082 as Amended; Prescription Drug User Fee Amendments of 2007
5/9/07	Senate	Rejected	Session 1, roll call 156: On the Amendment Durbin Amdt. No. 1034; To reduce financial conflict of interest in FDA Advisory Panels.
5/9/07	Senate	Agreed to	Session 1, roll call 155: On the Amendment Grassley Amdt. No. 998; To provide for the application of stronger civil penalties for violations of approved risk evaluation and mitigation strategies.
5/9/07	Senate	Rejected	Session 1, roll call 154: On the Amendment Grassley Amdt. No. 1039; To clarify the authority of the Office of Surveillance and Epidemiology with respect to postmarket drug safety pursuant to recommendations by the Institute of Medicine.
5/7/07	Senate	Agreed to	Session 1, roll call 151: On the Amendment Cochran Amdt. No. 1010; To protect the health and safety of the public.
5/2/07	Senate	Agreed to	Session 1, roll call 149: On the Amendment Durbin Amdt. No. 1022, as Modified; To ensure the safety of human and pet food.
5/2/07	Senate	Rejected	Session 1, roll call 148: On the Amendment Allard Amdt. No. 982; To strike provisions related to market exclusivity.